Paloma Partners’s Insmed INSM Stock Holding History

Paloma Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-177	Closed	-$12.9K	–	658
2024 Q3	$12.9K	Sell	177 -63	-26%	-$4.65K	﹤0.01%	1094
2024 Q2	$16.1K	Buy	+240	New	+$9.31K	﹤0.01%	1192
2021 Q3	–	Sell	-3,546	Closed	-$101K	–	1472
2021 Q2	$101K	Buy	+3,546	New	+$105K	﹤0.01%	1648
2020 Q1	–	Sell	-13,526	Closed	-$323K	–	1630
2019 Q4	$323K	Buy	+13,526	New	+$275K	﹤0.01%	1694

Other funds holding INSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paloma Partners's INSM Position: Q4 2024 in Review

Paloma Partners sold out of Insmed (INSM) in Q4 2024, closing a stake of 177 shares — an estimated $12.9K sold.

Paloma Partners first reported a position in INSM in Q4 2019 and held it in 4 quarters. The position peaked at $323K in Q4 2019. 438 funds tracked by Wall St. Rank hold INSM as of Q4 2024.

Paloma Partners reported no remaining Insmed position as of Q4 2024 after selling out during the quarter.
Paloma Partners sold 177 Insmed shares in Q4 2024, an estimated $12.9K.
Paloma Partners first reported a position in Insmed in Q4 2019 and held it in 4 quarters.
Paloma Partners's Insmed position peaked at $323K in Q4 2019.
438 funds tracked by Wall St. Rank held Insmed as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.